Loading, please wait ...


News Analytics

b75aa58baa849811f2428a8d6975448548d44026 200x200 jpg?fit=crop&auto=format.
“We thank all the patients, investigators, and healthcare professionals, as well as our employees fpr their active participation in this study.” In the international, multicenter, open-label phase 3 trial, investigators analyzed the safety, tolerability, and efficacy of intravenous balixafortide in combination with eribulin compared with eribulin alone in the treatment of patients with HER2-negative, locally recurrent or metastatic breast cancer.2 ...

Subject Matter

  • Healthcare 100.00%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions